IRIS UniCatt

Schinzari, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.014
AS - Asia 2.398
EU - Europa 2.300
SA - Sud America 496
AF - Africa 86
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 5
Totale 8.313
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.902
SG - Singapore 1.147
DE - Germania 579
CN - Cina 548
SE - Svezia 501
BR - Brasile 414
IT - Italia 364
IN - India 168
FR - Francia 163
VN - Vietnam 143
GB - Regno Unito 127
IE - Irlanda 117
FI - Finlandia 84
ID - Indonesia 77
PL - Polonia 77
UA - Ucraina 71
CA - Canada 59
HK - Hong Kong 57
RU - Federazione Russa 51
TR - Turchia 45
BD - Bangladesh 40
CI - Costa d'Avorio 38
MX - Messico 37
ES - Italia 33
AR - Argentina 27
JP - Giappone 27
IQ - Iraq 25
AT - Austria 23
BE - Belgio 23
KR - Corea 23
NL - Olanda 20
ZA - Sudafrica 19
IR - Iran 17
EC - Ecuador 15
AU - Australia 13
CZ - Repubblica Ceca 13
RO - Romania 12
AE - Emirati Arabi Uniti 11
CO - Colombia 11
VE - Venezuela 10
MA - Marocco 9
PK - Pakistan 9
UZ - Uzbekistan 9
JO - Giordania 7
PE - Perù 7
CH - Svizzera 6
SA - Arabia Saudita 6
AZ - Azerbaigian 5
EG - Egitto 5
IL - Israele 5
LT - Lituania 5
NP - Nepal 5
SN - Senegal 5
CL - Cile 4
GR - Grecia 4
LA - Repubblica Popolare Democratica del Laos 4
LV - Lettonia 4
PA - Panama 4
UY - Uruguay 4
CY - Cipro 3
DZ - Algeria 3
EU - Europa 3
HR - Croazia 3
LU - Lussemburgo 3
NO - Norvegia 3
PH - Filippine 3
PY - Paraguay 3
TT - Trinidad e Tobago 3
BG - Bulgaria 2
BN - Brunei Darussalam 2
CR - Costa Rica 2
ET - Etiopia 2
GE - Georgia 2
IS - Islanda 2
JM - Giamaica 2
KZ - Kazakistan 2
MD - Moldavia 2
PT - Portogallo 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
HN - Honduras 1
HU - Ungheria 1
KE - Kenya 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
KY - Cayman, isole 1
LB - Libano 1
LK - Sri Lanka 1
ML - Mali 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
Totale 8.308
Salva come PNG Salva come JPEG
Città #
Singapore 602
Chandler 481
Ashburn 289
New York 131
Los Angeles 119
Beijing 118
Dublin 116
Rome 83
Jakarta 73
Hyderabad 71
Warsaw 71
Wilmington 70
Hefei 65
Dallas 63
San Mateo 63
Ann Arbor 56
Fairfield 56
Hong Kong 54
Frankfurt am Main 52
Munich 52
Ho Chi Minh City 49
Milan 49
Boston 46
Princeton 46
São Paulo 46
Nanjing 44
Helsinki 43
Jacksonville 42
Chicago 39
Marseille 39
Abidjan 38
Hanoi 38
Dearborn 35
Houston 35
North Bergen 34
Cattolica 33
Moscow 31
Seattle 31
The Dalles 30
London 28
Redwood City 26
Nürnberg 25
Tokyo 25
Woodbridge 25
Cambridge 24
Orem 24
Redmond 24
Brooklyn 23
Brussels 23
Santa Clara 23
Falkenstein 22
Nuremberg 22
Seoul 22
Kent 21
Bremen 20
Buffalo 20
Denver 19
Mexico City 18
Boardman 17
Izmir 17
Montreal 17
Nanchang 17
Phoenix 17
Shanghai 17
Rio de Janeiro 15
Toronto 15
Chennai 14
Falls Church 14
Stockholm 14
Atlanta 13
Lappeenranta 13
Turku 13
Augusta 12
Hebei 12
Mumbai 11
Norwalk 11
Vienna 11
Changsha 10
Düsseldorf 10
Lawrence 10
Leawood 10
Manchester 10
San Francisco 10
Amsterdam 9
Ankara 9
Guangzhou 9
Johannesburg 9
Lauterbourg 9
Poplar 9
Washington 9
Belo Horizonte 8
Paris 8
Pune 8
Amman 7
Brno 7
Erbil 7
Guayaquil 7
Kish 7
Lima 7
Miami 7
Totale 4.333
Salva come PNG Salva come JPEG
Nome #
Pembrolizumab as first-line treatment for metastatic uveal melanoma 322
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 216
Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo 173
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases 169
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients 162
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 155
Risk factors for pancreas and lung neuroendocrine neoplasms: a case–control study 152
Are TKIs favourable for the elderly with non-small-cell lung cancer? 141
Contact skin radiotherapy (brachytherapy) for the treatment of non-melanoma skin cancers during COVID-19 pandemic 141
7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study 140
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 139
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 137
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 136
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 133
Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review 132
Multidisciplinary ocular and periocular cancers meetings: implementation in a tertiary referral center and analysis over a 12-months period 130
Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity 128
IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients 128
Hyperthermic intrathoracic chemotherapy combined to iterative cytoreductive surgery to treat a pleural carcinosis from psudomixoma peritonei. A case report 119
Gene expression profiling of pancreas neuroendocrine tumors with different ki67‐based grades 118
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 117
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. 115
Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study 114
Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients 113
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis. 111
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer? 109
Immunological backbone of uveal melanoma: Is there a rationale for immunotherapy? 108
Skin cancer triage and management during COVID-19 pandemic. 108
Immune-checkpoint inhibitors in renal transplanted patients affected by melanoma: A systematic review 107
Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma 106
Cardiac metastasis from renal cell carcinoma successfully treated with pazopanib: impact of TKIs' antiangiogenic activity. 105
Methylation study of the Paris system for reporting urinary (TPS) categories 105
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma 104
Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy: A single institution phase II study 103
First-line treatment of advanced biliary ducts carcinoma: A randomized phase II study evaluating 5-FU/LV Plus oxaliplatin (Folfox 4) versus 5-FU/LV (de gramont regimen) 102
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 102
Targeted Therapy in Advanced Gastric Carcinoma:the Future is Beginning 101
Conjunctival melanoma: Genetic and epigenetic insights of a distinct type of melanoma 101
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 100
The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration 99
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 97
Successful "on- demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors. 97
Biomarkers of response to advanced prostate cancer therapy 96
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues 95
Proteomics of Pancreatic Neuroendocrine Tumors: A Systematic Review 94
The role of stereotactic radiotherapy in addition to immunotherapy in the management of melanoma brain metastases: results of a systematic review 93
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 92
Prognostic factors affecting survival after pulmonary resection of metastatic renal cell carcinoma: A multicenter experience 92
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways 90
Long term follow up of a pilot study with neoadjuvant EEP ( epidoxorubicin, Etoposide and Cisplatin) in gastric cancer. 90
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 89
TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin Pathway 89
Surgical Resection of Pulmonary Metastases from Melanoma in Oligometastatic Patients: Results from a Multicentric Study in the Era of Immunoncology and Targeted Therapy 88
Efficacy of immune checkpoint inhibitors in different types of melanoma 86
The role of postoperative radiotherapy in eccrine porocarcinoma: a multidisciplinary systematic review 85
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? 84
Radiomics to predict immunotherapy efficacy in advanced renal cell carcinoma: A retrospective study 82
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin? 82
The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer 80
Upfront Oxaliplatin–Fluoropyrimidine Chemotherapy and Somatostatin Analogues in Advanced Well-Differentiated Gastro-Entero-Pancreatic Neuroendocrine Tumors 78
Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer 78
Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study 77
Unconventional radiotherapy to enhance immunotherapy efficacy in bulky tumors: a case report 77
The Role of Postoperative Radiotherapy in the Management of Dermatofibrosarcoma Protuberans: A Multidisciplinary Systematic Review 75
Line-Field Confocal Optical Coherence Tomography Evaluation of Eyelid Skin Lesions 71
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study. 71
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 71
SOMATOSTATIN ANALOGUES VS ACTIVE SURVEILLANCE IN SMALL PANCREATIC NEUROENDOCRINE TUMORS 68
“Skin rashes” and immunotherapy in melanoma: distinct dermatologic adverse events and implications for therapeutic management 68
The Role of Multidisciplinary Ocular and Periocular Cancers Meetings in Uveal Melanoma Management: A 2-Year Analysis 64
Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment 63
Atypical Presentation of Splenic Tissue Mimicking Neuroendocrine Tumor Relapse 62
A New Easy-to-Perform Flow Cytometry Assay for Determining Bacterial- and Viral-Infection-Induced Polymorphonuclear Neutrophil and Monocyte Membrane Marker Modulation in Febrile Patients 60
Competitive testing of the WHO 2010 versus the WHO 2017 grading of pancreatic neuroendocrine neoplasms: Data from a large international cohort study 60
Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial 58
Direct effects of GnRH agonists in human hormone-sensitive endometrial cells 56
Targeted therapy in advanced gastric carcinoma: The future is beginning 53
Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study 52
Reduced expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in human colon cancer. 47
No evidence of association between psychological distress and pain relief in patients with bone metastases from castration-resistant prostate cancer treated with 223Radium 42
Is 18F-fluorodeoxyglucose the tracer of choice for functional imaging of neuroendocrine tumors grade 3? A case report 40
Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with Cancer 39
Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis 35
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study 34
Impact of en bloc extended R0 resections on oncological outcome of locally advanced adrenocortical carcinoma 27
Totale 8.428
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.827
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.827
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021164 0 0 0 0 0 9 33 9 31 28 50 4
2021/2022636 59 18 15 99 39 14 13 86 33 43 95 122
2022/20231.381 181 178 100 226 57 158 103 121 143 32 59 23
2023/2024762 35 169 47 41 31 111 52 33 14 34 106 89
2024/20251.737 35 54 124 70 144 71 70 59 232 210 321 347
2025/20262.611 598 123 271 628 835 156 0 0 0 0 0 0
Totale 8.428